This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
This page shows the results of your search for publications containing the term "Antipsychotics". See definition (new window)
Research in Developmental Disabilities
March, 35(3), pii: S0891-4222(13)00547-7
Diler R. S. , Firat S. , Avci A. (2002)
An open-label trial of risperidone in children with autism.
Current Therapeutic Research
January, 63(1), pp. 91-102.
Dinnissen M. et al. (2015)
Expert Opinion on Drug Metabolism and Toxicology
January, 11(1), pp. 111-124.
Dodig-Curković K. et al. (2011)
The treatment of autistic children with risperidone.
Collegiuum Antropologicum
35 pp. 297-301
Douglas-Hall P. et al.
3 pp. 143-153.
Medications for adolescents and young adults with autism spectrum disorders: A systematic review.
Pediatrics
130(4), pp. 717 -726.
Doyle C. A. , McDougle C. J. (2012)
Pharmacotherapy to control behavioral symptoms in children with autism.
Expert Opinion on Pharmacotherapy
13(11), pp. 1615-1629.
An introduction to the psychopharmacology of children and adolescents with autism spectrum disorder.
Journal of Child and Adolescent Psychiatric Nursing
May, 29(2), pp. 62-71.
Eissa N. et al.
Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder.
Frontiers in Neuroscience
Review of the pharmacotherapy of irritability of autism.
Journal of the Canadian Academy of Child and Adolescent Psychiatry
21(2), pp. 130-146.
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-90.
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-89.
Erickson C. A. et al. (2010)
Aripiprazole in autism spectrum disorders and fragile X syndrome.
Neurotherapeutics
7(3), pp. 258-263
Faretra G. , Dooher L. , Dowling J. (1970)
Comparison of haloperidol and fluphenazine in disturbed children.
American Journal of Psychiatry
126(11), pp. 1670-1673.
Farmer C. A. , Aman M. G. (2011)
Aripiprazole for the treatment of irritability associated with autism.
Expert Opinion on Pharmacotherapy
12(4), pp. 635-640
Farmer C. A. , Thurm A. , Grant P. J. (2013)
Pharmacotherapy for the core symptoms in autistic disorder: Current status of the research.
Drugs
73(4), pp. 303-314.